| ACE2 | angiotensin converting enzyme 2 |
| AChE | acetylcholinesterase |
| AD | Alzheimer’s disease |
| ADP | adenosine-5′-diphosphate |
| CB1 | cannabinoid receptor 1 |
| CB2 | cannabinoid receptor 2 |
| CL | clearance |
| CNS | Central Nervous System |
| COVID-19 | Coronavirus disease 2019 |
| CXCR2 | CXC chemokine receptor 2 |
| DENV | dengue virus |
| ECAT | electrolytic-mediated carotid arterial thrombosis |
| ENR | enoyl-acyl-carrier protein reductase |
| FLIPR | fluorescent imaging plate reader |
| FST | forced swim test |
| HD | Huntington’s disease |
| HFF | human foreskin fibroblast |
| IGF-1R | insulin like growth factor I receptor |
| IL-6 | interleukin-6 |
| IP | interstitial pneumonia |
| K B | binding affinity |
| LPS | lipopolysaccharide |
| MenG | demethylmenaquinone methyltranferase |
| MERS | Swine flu |
| Ebola | Middle East respiratory syndrome |
| MES | maximal electroshock |
| MIC | minimum inhibitory concentration |
| MMV | Medicines for Malaria Venture |
| MRSA | methicillin-resistant S. aureus |
| MSSA | methicillin-sensitive S. aureus |
| NTDs | neglected tropical diseases |
| NTS | newly transformed schistosomula |
| PGR | plant growth regulator |
| PA | platelet aggregation |
| PD | Parkinson’s disease |
| PZQ | praziquantel |
| SARS | severe acute respiratory syndrome |
| SARS-CoV | respiratory syndrome coronavirus |
| SARS-CoV-2 | respiratory syndrome coronavirus 2 |
| scPTZ | subcutaneous pentylenetetrazole |
| sEH | soluble epoxide hydrolase |
| Sps | bacterial signal peptidase I enzyme |
| TB | tuberculosis |
| TCC | triclocarban |
| TRPV1 | transient receptor potential vanilloid 1 |
| TST | tail suspension test |
| Vdss | volume of distribution |
| VLA-4 | very late antigen-4 |
| VRSA | vancomycin-resistant S. aureus |
| WNV | West Nile virus |
| YFV | Yellow fever virus |
| ZIKV | Zika virus virus |